Cancer Research Horizons
Cancer Research Horizons is an investor named in the Raise Track Update as backing Alethio Therapeutics.
- Type
- Venture capital firm
About
Cancer Research Horizons participated in Alethio Therapeutics' $90 million Series A, announced on 2026-11-05.
This page is not indexed by search engines yet. It is promoted once it meets the quality gate for investor pages: a description from the firm's own website, a headquarters city and at least two two-sourced rounds on this site.
Funding rounds on RaiseTrack
| Company | Round | Date | Role |
|---|---|---|---|
| Alethio Therapeutics | Series A 2026 | 2026-11-05 | participant |
Sources
Last verified:
- https://alethiotherapeutics.com/alethio-therapeutics-raises-90-million-67-million-in-oversubscribed-series-a-financing-to-advance-a-new-generation-of-therapies-for-myeloproliferative-neoplasms/
Type: company announcement. Accessed 2026-11-05.
Alethio Therapeutics release, 5 November 2026. Names Cancer Research Horizons among the backers of the $90 million Series A. - https://www.biopharmadive.com/news/alethio-therapeutics-myeloproliferative-neoplasms-series-a/873775/
Type: reputable publication. Accessed 2026-11-05.
BioPharma Dive. Names Cancer Research Horizons among the backers of Alethio Therapeutics' $90 million Series A. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-11-05/
Type: other verified public source. Accessed 2026-11-05.
Raise Track Update for 2026-11-05. Names Cancer Research Horizons in Alethio Therapeutics' $90M Series A.